In brief
David Sinclair argues that aging is not simple wear and tear but a loss of biological information, mainly in the epigenome, the chemical layer that tells each cell what kind of cell it is. Because a backup copy of that information may exist in old cells, he says aging can be reset, and the first human trial, in blindness, is imminent.
The episode moves between hope and caution. Sinclair shows how lifestyle choices such as fasting, exercise, plants and supplements slow the loss of information today, then describes gene therapy that may reverse it tomorrow. He admits much is still proven only in mice and monkeys, and that living forever is unlikely soon.
Facts
Stated by the speakers. Each quote matches the transcript, which shows what was said, not that it is true.
David Sinclair says his lab's age-reversal technology has cured blindness in animals including primates.
“What we're finding in animals, that includes primates, is that we can cure things that have previously been impossible, including blindness, by the way.”
0:10:33 · David Sinclair · Blindness therapy
Sinclair's planned eye therapy introduces three genes into the optic nerve and activates them for six to eight weeks.
“we're introducing a set of three genes into this optic nerve at the back of the eye and turning them on for six to eight weeks.”
0:13:07 · David Sinclair · Gene therapy · 2026
An independent lab used Sinclair's three-gene technology in very old mice by injecting it into the vein.
“They injected into the vein of the mouse the old mice, uh, and turned it on in these really old mice.”
0:14:41 · David Sinclair · Mouse lifespan
Sinclair recalls futurist Ray Kurzweil predicting the singularity around the 2040s, though Sinclair is skeptical.
“Ray Kurzweil said, it's coming soon.”
0:21:08 · David Sinclair · Singularity · 2040s
Sinclair says James Watson, co-discoverer of the DNA structure, died the month before the interview.
“my friend, uh, Jim Watson, uh, died recently, uh, last month, who he and his colleague discovered that D N A”
0:25:07 · David Sinclair · DNA discovery · 2025
Sinclair's information theory of aging holds that loss of epigenetic control information, not DNA itself, drives aging.
“the information theory of aging states that the information that's in a cell, which includes the D N A, but actually more importantly for aging, is the control systems, the epigenome.”
0:28:17 · David Sinclair · Information theory
Sinclair's lab created 'ice mice', named for inducible changes to the epigenome, to test whether DNA breaks cause aging.
“We call them the ice mice. Ice stands for inducible changes to the epigenome, and we were able to induce these changes.”
0:34:46 · David Sinclair · Ice mice
The ice mice carried a slime mold gene, activated by tamoxifen, that cuts DNA without causing cancer or mutations.
“turned on a gene from a slime mold, something you might find in the forest, that breaks D N A of the mouse, but does it in a way that doesn't cause cancer or mutations”
0:35:40 · David Sinclair · Ice mice
Sinclair says the treated mice aged much faster than untreated twins, with gray fur and age-related diseases about ten months later.
“they were super gray and super old and had all the diseases of aging 50 faster than their twins that we didn't treat.”
0:36:46 · David Sinclair · Accelerated aging
Sinclair cites a Harvard long-term study of World War II veterans in saying healthy habits can add about 14 years of life.
“This is based on a study that came out from Harvard, a long-term study of the lifespan of World War II veterans.”
0:40:28 · David Sinclair · Lifespan study
Sinclair says the bristlecone pine is the longest-lived tree and is poisonous, so little eats it.
“the longest lived tree in the world, it can live many thousands of years.”
0:45:31 · David Sinclair · Longevity evolution
Sinclair says the US government blocked a foreign investment of over $100 million in a company he serves on the board of, citing the sensitivity of age-reversal technology.
“A large investment into, uh, the com, one of the companies that I, uh, sit on the board of, was blocked because the U S government claimed that the technology was too dangerous”
0:52:27 · David Sinclair · Geopolitics
Sinclair says a gram of NMN swallowed by a human typically doubles NAD levels in the body.
“When you give a human N M N by swallowing it, a gram of it, you can typ. You typically double the amount of N A D in your body.”
1:25:26 · David Sinclair · NMN
Sinclair says deep protein cleanup through chaperone-mediated autophagy happens after about two and a half to three days of fasting.
“the true, real deep clean cleansing of old proteins and damage damaged proteins happens after two and a half to three days. And it's called chaperone-mediated autophagy.”
1:28:43 · David Sinclair · Fasting
Sinclair says one of his 1996 papers raised red wine sales by about 30%.
“One of my papers in 1996 caused red wine sales to go up 30% and stayed up.”
1:37:17 · David Sinclair · Red wine · 1996
Sinclair says he has taken a statin to lower LDL cholesterol since age 30.
“So I've actually been on a statin to lower my L D L since I was thirty.”
1:41:10 · David Sinclair · Statins
Sinclair says spermidine was first crystallized by Antonie van Leeuwenhoek, which is why it is named for its origin in semen.
“It was crystallized by, I believe, Anthony von Leeuwenhoek, one of the first microscopists and microbiologists.”
1:57:37 · David Sinclair · Spermidine
Sinclair takes daily baby aspirin despite medical groups no longer recommending it for the average person, citing his high cardiovascular risk.
“I take a baby aspirin every day, even though some doctors um, and some institutions of doctors say, don't take it anymore”
2:00:29 · David Sinclair · Aspirin
Sinclair says the trial material was manufactured in Europe over about a year at a cost of roughly $10 million.
“We just made a bunch of this in Europe for the clinical trial that's gonna begin.”
2:08:25 · David Sinclair · Clinical trial
Sinclair's gene therapy uses an AAV2 delivery vector designed to target retinal nerves and is said to be ready for human use pending FDA approval.
“It's called an A A V two. Um, long story short, these are ready to go into humans.”
2:09:54 · David Sinclair · AAV2 vector
Sinclair's therapy uses the antibiotic doxycycline to switch the three rejuvenation genes on.
“We give them doxycycline. It's used for malaria, it's used for Lyme disease, and we're using it in this case to turn these genes on.”
2:12:06 · David Sinclair · Gene switch
Sinclair says the company developing the eye therapy is the private firm Life Biosciences.
“The company, people might want to know, it's called Life Biosciences, it's a private company.”
2:14:00 · David Sinclair · Life Biosciences
Sinclair says AI was used to screen about 8 billion candidate molecules in search of a pill that reproduces the effect of the three genes.
“We screened about 8 billion candidates using A I, and right now we're doing the bench lab work to see if one of them or more works.”
2:14:26 · David Sinclair · AI drug discovery
Sinclair says he thinks there is a better than 50% chance that reality is a simulation.
“I think there's a better than 50% chance that this is simulated.”
2:18:31 · David Sinclair · Simulation theory